Neurosense Therapeutics is trading 5.29% up at $6.97 after closing at $6.62 on September 21, 2026; no new company-specific announcement clearly explains the September 22 advance.
- The latest identified company item was a September 10 conference presentation notice, updated September 21.
- The gain appears to be an unexplained continuation of recent volatility rather than a confirmed catalyst.
- Broader markets are only modestly mixed on September 22, so global sentiment provides limited support.